Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China · Delayed Price · Currency is CNY 10.30
-0.23 (-2.18%)
Apr 17, 2026, 11:00 AM CST
SHE:300434 Revenue
Sichuan Goldstone Asia Pharmaceutical had revenue of 216.79M CNY in the quarter ending September 30, 2025, a decrease of -7.64%. This brings the company's revenue in the last twelve months to 1.05B, down -7.43% year-over-year. In the year 2024, Sichuan Goldstone Asia Pharmaceutical had annual revenue of 1.10B, down -8.84%.
Revenue (ttm)
1.05B
Revenue Growth
-7.43%
P/S Ratio
4.01
Revenue / Employee
544.22K
Employees
1,937
Market Cap
4.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.10B | -106.84M | -8.84% |
| Dec 31, 2023 | 1.21B | -33.40M | -2.69% |
| Jan 1, 2023 | 1.24B | 189.10M | 17.95% |
| Jan 1, 2022 | 1.05B | 276.21M | 35.53% |
| Dec 31, 2020 | 777.30M | -228.31M | -22.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Contemporary Amperex Technology | 423.70B |
| Zhejiang Development Group Co.,Ltd | 225.31B |
| China CSSC Holdings | 94.94B |
| Sungrow Power Supply | 89.18B |
| Beijing-Shanghai High-Speed Railway | 42.61B |
| Shenzhen Cheng Chung Design | 1.35B |
| Shaanxi Baoguang Vacuum Electric Device | 1.24B |
| Jiangsu Wuyang Automation Control Technology | 998.48M |